MCID: PST048
MIFTS: 38

Postural Orthostatic Tachycardia Syndrome

Categories: Rare diseases, Cardiovascular diseases, Neuronal diseases, Genetic diseases

Aliases & Classifications for Postural Orthostatic Tachycardia Syndrome

MalaCards integrated aliases for Postural Orthostatic Tachycardia Syndrome:

Name: Postural Orthostatic Tachycardia Syndrome 12 53 54 73
Mitral Valve Prolapse Syndrome 12 73
Postural Tachycardia Syndrome 53 54
Neurocirculatory Asthenia 12 73
Irritable Heart 12 73
Familial Orthostatic Tachycardia Due to Norepinephrine Transporter Deficiency 12
Postural Tachycardia Syndrome Due to Net Deficiency 12
Orthostatic Intolerance Due to Net Deficiency 12
Chronic Othostatic Intolerance 53
Orhtostatic Intolerance 12
Soldiers Heart 12
Pots 53

Classifications:



External Ids:

Disease Ontology 12 DOID:0111154
ICD10 33 I95.1

Summaries for Postural Orthostatic Tachycardia Syndrome

NINDS : 54 Postural orthostatic tachycardia syndrome (POTS) is one of a group of disorders that have orthostatic intolerance (OI) as their primary symptom. OI describes a condition in which an excessively reduced volume of blood returns to the heart after an individual stands up from a lying down position. The primary symptom of OI is lightheadedness or fainting. In POTS, the lightheadedness or fainting is also accompanied by a rapid increase in heartbeat of more than 30 beats per minute, or a heart rate that exceeds 120 beats per minute, within 10 minutes of rising. The faintness or lightheadedness of POTS are relieved by lying down again. Anyone at any age can develop POTS, but the majority of individuals affected (between 75 and 80 percent) are women between the ages of 15 to 50 years of age. Some women report an increase in episodes of POTS right before their menstrual periods. POTS often begins after a pregnancy, major surgery, trauma, or a viral illness. It may make individuals unable to exercise because the activity brings on fainting spells or dizziness. Doctors aren't sure yet what causes the reduced return of blood to the heart that occurs in OI, or why the heart begins to beat so rapidly in POTS.  Current thinking is that there are a number of mechanisms.  Some individuals have peripheral denervation (neuropathic POTS); some have symptoms that are due to sustained or parosyxmal overactivity of the sympathetic nervous system (hyperadrenergic POTS); and many individuals with POTS have significant deconditioning. 

MalaCards based summary : Postural Orthostatic Tachycardia Syndrome, also known as mitral valve prolapse syndrome, is related to syncope and autonomic dysfunction, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Postural Orthostatic Tachycardia Syndrome is SLC44A1 (Solute Carrier Family 44 Member 1). The drugs Bisoprolol and Propranolol have been mentioned in the context of this disorder. Affiliated tissues include heart, testes and endothelial.

NIH Rare Diseases : 53 Postural orthostatic tachycardia syndrome (POTS) is a condition characterized by too little blood returning to the heart when moving from a lying down to a standing up position (orthostatic intolerance). Orthostatic Intolerance causes lightheadedness or fainting that can be eased by lying back down. In people with POTS, these symptoms are also accompanied by a rapid increase in heart rate. Although POTS can affect men and women of all ages, most cases are diagnosed in women between the ages of 15 and 50. The cause of POTS is unknown. However, episodes often begin after major surgery, trauma, or a viral illness. In women, episodes may also begin after pregnancy and the symptoms may worsen or the number of episodes may increase right before menstruation. The goal of treatment is to increase blood flow and improve circulatory problems that may be causing POTS.

Disease Ontology : 12 A heart conduction disease characterized by orthostatic intolerance that has material basis in heterozygous mutation in the SLC6A2 gene on chromosome 16q12.2.

Wikipedia : 76 Postural orthostatic tachycardia syndrome (POTS) is a condition in which a change from lying to standing... more...

Related Diseases for Postural Orthostatic Tachycardia Syndrome

Graphical network of the top 20 diseases related to Postural Orthostatic Tachycardia Syndrome:



Diseases related to Postural Orthostatic Tachycardia Syndrome

Symptoms & Phenotypes for Postural Orthostatic Tachycardia Syndrome

UMLS symptoms related to Postural Orthostatic Tachycardia Syndrome:


angina pectoris, chest pain, edema

Drugs & Therapeutics for Postural Orthostatic Tachycardia Syndrome

Drugs for Postural Orthostatic Tachycardia Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 147)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bisoprolol Approved Phase 4 66722-44-9 2405
2
Propranolol Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable,Early Phase 1 525-66-6 4946
3 Adrenergic Agents Phase 4,Phase 2,Phase 1,Not Applicable,Early Phase 1
4 Adrenergic Antagonists Phase 4,Phase 2,Phase 1,Not Applicable,Early Phase 1
5 Adrenergic beta-1 Receptor Antagonists Phase 4,Phase 2,Phase 1
6 Adrenergic beta-Antagonists Phase 4,Phase 2,Phase 1,Not Applicable,Early Phase 1
7 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 1,Early Phase 1,Not Applicable
8 Antihypertensive Agents Phase 4,Phase 2,Phase 1,Early Phase 1,Not Applicable
9 Autonomic Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
10 Neurotransmitter Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
11 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
12 Sympatholytics Phase 4,Phase 2,Phase 1
13 Bromides Phase 4,Phase 1,Not Applicable,Early Phase 1
14 Cholinergic Agents Phase 4,Phase 1,Phase 2,Not Applicable,Early Phase 1
15 Cholinesterase Inhibitors Phase 4,Phase 1,Not Applicable,Early Phase 1
16 Pyridostigmine Bromide Phase 4,Phase 1,Not Applicable,Early Phase 1 101-26-8
17 Vasodilator Agents Phase 4,Phase 1,Phase 2,Not Applicable,Early Phase 1
18
Dopamine Approved Phase 2, Phase 3,Phase 1,Not Applicable 51-61-6, 62-31-7 681
19
Carbidopa Approved Phase 2, Phase 3 28860-95-9 34359 38101
20 Dopamine Agents Phase 2, Phase 3,Phase 1,Not Applicable
21 Protective Agents Phase 2, Phase 3,Phase 1,Early Phase 1,Not Applicable
22 Antiparkinson Agents Phase 2, Phase 3,Phase 1
23 Aromatic Amino Acid Decarboxylase Inhibitors Phase 2, Phase 3
24 Pharmaceutical Solutions Phase 3,Phase 1,Phase 2
25 Plasma Substitutes Phase 3
26
Metoprolol Approved, Investigational Phase 2 37350-58-6, 51384-51-1 4171
27
Nitric Oxide Approved Phase 1, Phase 2,Early Phase 1 10102-43-9 145068 160954
28
Droxidopa Approved, Investigational Phase 2,Phase 1 23651-95-8 443940
29
Acetazolamide Approved, Vet_approved Phase 1, Phase 2 59-66-5 1986
30
Armodafinil Approved, Investigational Phase 1, Phase 2,Early Phase 1 112111-43-0
31
AT-101 Approved, Investigational Phase 1, Phase 2 90141-22-3, 652-67-5 12597
32
Clonidine Approved Phase 1, Phase 2 4205-90-7 2803
33
Entacapone Approved, Investigational Phase 1, Phase 2 130929-57-6 5281081
34
Indomethacin Approved, Investigational Phase 1, Phase 2 53-86-1 3715
35
Isosorbide Dinitrate Approved, Investigational Phase 1, Phase 2 87-33-2 6883
36
Mecamylamine Approved, Investigational Phase 1, Phase 2 60-40-2 4032
37
Memantine Approved, Investigational Phase 1, Phase 2 19982-08-2 4054
38
Midodrine Approved Phase 1, Phase 2 133163-28-7, 42794-76-3 4195
39
Modafinil Approved, Investigational Phase 1, Phase 2,Early Phase 1 68693-11-8 4236
40
Octreotide Approved, Investigational Phase 1, Phase 2 83150-76-9 383414 6400441
41
Sertraline Approved Phase 1, Phase 2 79617-96-2 68617
42
Iron Approved Phase 1, Phase 2 7439-89-6 23925
43
Atenolol Approved Phase 1, Phase 2 29122-68-7 2249
44
Melatonin Approved, Nutraceutical, Vet_approved Phase 1, Phase 2 73-31-4 896
45 Adrenergic Agonists Phase 1, Phase 2,Not Applicable,Early Phase 1
46 Adrenergic alpha-2 Receptor Agonists Phase 1, Phase 2
47 Adrenergic alpha-Agonists Phase 1, Phase 2,Not Applicable,Early Phase 1
48 Antioxidants Phase 1, Phase 2,Early Phase 1
49 Cholinergic Antagonists Phase 1, Phase 2
50 Vasoconstrictor Agents Phase 1, Phase 2,Not Applicable,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 60)
# Name Status NCT ID Phase Drugs
1 Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS) Completed NCT02171988 Phase 4 Propranolol;Bisoprolol;Propranolol+pyridostigmine;Bisoprolol+pyridostgmine
2 Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome Recruiting NCT03182725 Phase 3 Ivabradine;Placebo
3 Peripheral Dopamine in Postural Tachycardia Syndrome Active, not recruiting NCT00685919 Phase 2, Phase 3 Carbidopa;Placebo
4 A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS Not yet recruiting NCT03365414 Phase 3 Normal Saline 0.9% Infusion Solution Bag
5 The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome Unknown status NCT01761825 Phase 2 ivabradine
6 Cardiovascular Effects of Selective I(f)-Channel Blockade Unknown status NCT00865917 Phase 2 beta-blocker (Metoprolol);I(f)-blocker (ivabradine);Placebo
7 Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS) Recruiting NCT02558972 Phase 2 Northera (Droxidopa);Placebo;Northera (Droxidopa);Placebo
8 Treatment of Orthostatic Intolerance Active, not recruiting NCT00262470 Phase 1, Phase 2 Acetazolamide;Atomoxetine;Clonidine;Entacapone;Entacapone & Propranolol;Atomoxetine & Propranolol;Indomethacin;Mecamylamine;Isosorbide Dinitrate;Midodrine;Modafinil;Octreotide;Propranolol;Modafinil & Propranolol;Sertraline;memantine
9 Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS) Terminated NCT01978535 Phase 1, Phase 2 Iron infusion;Normal saline infusion
10 Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist Terminated NCT03070730 Phase 1, Phase 2 Droxidopa;Atenolol;Placebos
11 Autonomic Nervous System and Chronic Fatigue Syndrome Completed NCT00580619 Phase 1 L-NMMA trimethaphan;methyldopa
12 Vagal Stimulation in POTS Recruiting NCT03124355 Phase 1 placebo sugar pill;Pyridostigmine Pill;Galantamine Pill
13 Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients Active, not recruiting NCT02854683 Phase 1 Normal Saline
14 High Sodium Diet and External Abdominal Compression in POTS Terminated NCT01771484 Phase 1
15 Palpitations and Tachycardia in Fibromyalgia Syndrome Unknown status NCT01147263
16 Cognitive Dysfunction in Postural Tachycardia Syndrome Completed NCT01366963
17 The Renin-Aldosterone Axis in Postural Tachycardia Syndrome Completed NCT00962949 Not Applicable Angiotensin II
18 Assessment of Vascular Endothelial Function in Postural Tachycardia Syndrome Completed NCT01308099
19 Local Vasoconstriction in Postural Tachycardia Syndrome Completed NCT01210430 Early Phase 1 Losartan;Ascorbic Acid (Vitamin C);Normal Saline
20 Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea Completed NCT00728026
21 Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects Completed NCT01617616
22 Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life Completed NCT01367977
23 Renal Salt Handling in Postural Tachycardia Syndrome Following Dietary Dopa Administration Completed NCT01064739 Early Phase 1
24 EEG Characteristics in Youth POTS and/or Syncope Completed NCT02167412
25 Abdominal and Lower Extremity Compression During Tilt Table Testing in Adolescent POTS Patients Completed NCT01795469 Not Applicable
26 Qualitative Sweat Distribution During Tilt Table Procedure Completed NCT02329548 Not Applicable
27 Effect of Exercise in OI Completed NCT00770484 Not Applicable Propranolol then Placebo;Placebo then Propranolol
28 Objective Sleep Disturbances in Orthostatic Intolerance Completed NCT00581022
29 Hypnosis in Autonomic Function Completed NCT00061009
30 MRI to Assess the Effects of Dysautonomia and Chronic Nausea on Brain Transmitters Completed NCT01692561
31 PET Scan in Patients With Neurocardiologic Disorders Completed NCT00001418
32 Gastrointestinal Symptoms in Postural Orthostatic Tachycardia Syndrome Recruiting NCT03263819
33 A Study of Pyridostigmine in Postural Tachycardia Syndrome Recruiting NCT00409435 Not Applicable pyridostigmine;Placebo
34 POTS Adrenergic Ab (CIHR Aims #1&2) Recruiting NCT02673996 Phenylephrine;Isoproterenol
35 Autoimmune Basis for Postural Tachycardia Syndrome Recruiting NCT02725060 Not Applicable phenylephrine;isoproterenol
36 Alterations of Attention in POTS Depending on Body Position and Hydration Recruiting NCT03253120 Not Applicable
37 Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS Recruiting NCT03261570 Early Phase 1 Pyridostigmine;Digoxin;Placebo
38 Pathophysiology of Orthostatic Intolerance Recruiting NCT00608725 Not Applicable Intrinsic Heart Rate
39 Vitamin D Deficiency and Dysautonomia Recruiting NCT03032328 Not Applicable
40 Implementation of Transdx Group for POTS Recruiting NCT03185247 Not Applicable
41 Clinical Autonomic Disorders: A Training Protocol Recruiting NCT02154009
42 External Influences Upon Ocular Homeostasis Recruiting NCT00338065 Not Applicable
43 Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic Recruiting NCT00921986
44 Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome Active, not recruiting NCT02196376
45 Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS) Active, not recruiting NCT00962728 Not Applicable
46 Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS) Active, not recruiting NCT01764711 Not Applicable Cosyntropin administration
47 Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening Active, not recruiting NCT01783288 Not Applicable
48 Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome Active, not recruiting NCT01563107 Not Applicable
49 Dietary Salt in Postural Tachycardia Syndrome Active, not recruiting NCT01547117 Not Applicable
50 Transdermal Vagal Stimulation for POTS Active, not recruiting NCT02281097 Not Applicable

Search NIH Clinical Center for Postural Orthostatic Tachycardia Syndrome

Genetic Tests for Postural Orthostatic Tachycardia Syndrome

Anatomical Context for Postural Orthostatic Tachycardia Syndrome

MalaCards organs/tissues related to Postural Orthostatic Tachycardia Syndrome:

41
Heart, Testes, Endothelial, Bone, Brain, Temporal Lobe, Skin

Publications for Postural Orthostatic Tachycardia Syndrome

Articles related to Postural Orthostatic Tachycardia Syndrome:

(show top 50) (show all 163)
# Title Authors Year
1
Demographics of a large paediatric Postural Orthostatic Tachycardia Syndrome Program. ( 29357955 )
2018
2
Activity and Exercise Intolerance After Concussion: Identification and Management of Postural Orthostatic Tachycardia Syndrome. ( 29864098 )
2018
3
Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review. ( 29330767 )
2018
4
Periodic facial erythema in a patient with postural orthostatic tachycardia syndrome. ( 28976015 )
2018
5
The patient perspective: What postural orthostatic tachycardia syndrome patients want physicians to know. ( 29903594 )
2018
6
Youth with Chronic Pain and Postural Orthostatic Tachycardia Syndrome (POTS): Treatment Mediators of Improvement in Functional Disability. ( 29508112 )
2018
7
Autoimmunity in postural orthostatic tachycardia syndrome: Current understanding. ( 29909990 )
2018
8
From Postural Orthostatic Tachycardia Syndrome to Radiologically Isolated Syndrome. ( 29682372 )
2018
9
Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management. ( 29943373 )
2018
10
Autoimmune postural orthostatic tachycardia syndrome. ( 29687025 )
2018
11
Postural Orthostatic Tachycardia Syndrome and Its Unusual Presenting Complaints in Women: A Literature Minireview. ( 29876157 )
2018
12
Ivabradine in Postural Orthostatic Tachycardia Syndrome: Preliminary Experience in Children. ( 29027608 )
2018
13
Vagal nerve stimulation is beneficial in postural orthostatic tachycardia syndrome and epilepsy. ( 29529557 )
2018
14
Postural Orthostatic Tachycardia Syndrome during pregnancy: A systematic review of the literature. ( 29784553 )
2018
15
Postural orthostatic tachycardia syndrome in children and adolescents. ( 29778304 )
2018
16
Postural Orthostatic Tachycardia Syndrome (POTS) in Denmark: Increasingly recognized or new epidemic? ( 29530592 )
2018
17
Sleep disturbance linked to suicidal ideation in postural orthostatic tachycardia syndrome. ( 28442939 )
2017
18
Orthostatic Intolerance and Postural Orthostatic Tachycardia Syndrome in Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome, Hypermobility Type: Neurovegetative Dysregulation or Autonomic Failure? ( 28286774 )
2017
19
Comparison of Heart Rate Variability Parameters to the Autonomic Reflex Screen in Postural Orthostatic Tachycardia Syndrome and Neurogenic Orthostatic Hypotension. ( 29210841 )
2017
20
Incidence rates of Guillain BarrAc (GBS), chronic fatigue/systemic exertion intolerance disease (CFS/SEID) and postural orthostatic tachycardia syndrome (POTS) prior to introduction of human papilloma virus (HPV) vaccination among adolescent girls in Finland, 2002-2012. ( 28720463 )
2017
21
Unexplored relationship of sleep disturbances linked to suicidal ideation and behavior in postural orthostatic tachycardia syndrome. ( 28769598 )
2017
22
Differences in neurohumoral and hemodynamic response to prolonged head-up tilt between patients with high and normal standing norepinephrine forms of postural orthostatic tachycardia syndrome. ( 28522107 )
2017
23
Human Papillomavirus Vaccine and Postural Orthostatic Tachycardia Syndrome: A Review of Current Literature. ( 28689455 )
2017
24
Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System. ( 29061232 )
2017
25
Using an exercise program to improve activity tolerance in a female with postural orthostatic tachycardia syndrome: A case report. ( 28590791 )
2017
26
Cardiovascular testing in patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome type III. ( 28101744 )
2017
27
Postural Orthostatic Tachycardia Syndrome (POTS) - A novel member of the autoimmune family. ( 26846691 )
2016
28
Postural orthostatic tachycardia syndrome is associated with platelet storage pool deficiency. ( 27631244 )
2016
29
Stimulant medication and postural orthostatic tachycardia syndrome: a tale of two cases. ( 26968177 )
2016
30
Resolution of Postural Orthostatic Tachycardia Syndrome After CT-Guided, Percutaneous T2 Ethanol Ablation for Hyperhidrosis. ( 27558116 )
2016
31
Improvement in Functioning and Psychological Distress in Adolescents With Postural Orthostatic Tachycardia Syndrome Following Interdisciplinary Treatment. ( 26983448 )
2016
32
[Clinical characteristics of orthostatic hypertension with hemodynamic response of vasovagal syncope and postural orthostatic tachycardia syndrome in children and adolescents]. ( 27055424 )
2016
33
Cardiac responses to exercise distinguish postural orthostatic tachycardia syndrome variants. ( 27884959 )
2016
34
BASCULE syndrome, orthostatic cyanosis and postural orthostatic tachycardia syndrome: time for decanting old wine? ( 27479249 )
2016
35
Recognizing postural orthostatic tachycardia syndrome. ( 26967958 )
2016
36
Cardiovascular profile in postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome type III. ( 28005189 )
2016
37
The complexity of diagnosing postural orthostatic tachycardia syndrome:A influence of the diurnal variability. ( 26857333 )
2016
38
Postural orthostatic tachycardia syndrome (POTS) as presenting symptom of CIDP. ( 26879313 )
2016
39
Cooccurrence of Postural Orthostatic Tachycardia Syndrome with Two Different Clinical Entities. ( 27413567 )
2016
40
Droxidopa in the Treatment of Postural Orthostatic Tachycardia Syndrome. ( 27563801 )
2016
41
Human papillomavirus vaccines, complex regional pain syndrome, postural orthostatic tachycardia syndrome, and autonomic dysfunction - a review of the regulatory evidence from the European Medicines Agency. ( 27867145 )
2016
42
Use of an allostatic neurotechnology by adolescents with postural orthostatic tachycardia syndrome (POTS) is associated with improvements in heart rate variability and changes in temporal lobe electrical activity. ( 26645307 )
2016
43
Postural orthostatic tachycardia syndrome in a case of benign generalised joint hypermobilty. ( 27728664 )
2016
44
Postural orthostatic tachycardia syndrome for the otolaryngologist. ( 27578452 )
2016
45
Menstrual cycle phase does not affect sympathetic neural activity in women with postural orthostatic tachycardia syndrome. ( 25656420 )
2015
46
Reversible postural orthostatic tachycardia syndrome. ( 26244158 )
2015
47
Psychosocial Dimensions and Functioning in Youth With Postural Orthostatic Tachycardia Syndrome. ( 26581359 )
2015
48
An assessment of fatigue in patients with postural orthostatic tachycardia syndrome. ( 26537521 )
2015
49
"Doesn't Anyone Believe How I Feel?": Postural Orthostatic Tachycardia Syndrome (POTS). ( 25816441 )
2015
50
A survey-based analysis of symptoms in patients with postural orthostatic tachycardia syndrome. ( 25829642 )
2015

Variations for Postural Orthostatic Tachycardia Syndrome

Expression for Postural Orthostatic Tachycardia Syndrome

Search GEO for disease gene expression data for Postural Orthostatic Tachycardia Syndrome.

Pathways for Postural Orthostatic Tachycardia Syndrome

GO Terms for Postural Orthostatic Tachycardia Syndrome

Sources for Postural Orthostatic Tachycardia Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....